 |
|
|
| |
Telaprevir in Combination with Peginterferon Alfa-2a and Ribavirin Increased Sustained Virologic Response Rates in Treatment-naïve Patients Regardless of Race or Ethnicity
|
| |
| |
Reported by Jules Levin
EASL 2011 March 30-April3 Berlin Germany
GM Dusheiko1*, MW Fried2, R Reddy3, DR Nelson4, N Bzowej5, N Adda6, CI Wright6, L Bengtsson6, S George6, SL Flamm7
1Royal Free and University College, London, UK, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, 3University of Pennsylvania School of Medicine, Philadelphia, PA, 4University of Florida, Gainesville, FL, 5California Pacific Medical Center, San Francisco, CA, 6Vertex Pharmaceuticals Incorporated, Cambridge, MA, 7Northwestern University, Chicago, IL, USA.
*Address correspondence to: Professor Geoffrey M. Dusheiko, Centre for Hepatology, Royal Free Hospital & University College School Of Medicine Royal Free Hospital, London U.K.; Email: g.dusheiko@medsch.ucl.ac.uk
|
| |
|
|
|
|
|
